Rates of chronic kidney disease, deaths outpace other diseases

November 30, 2018

Advances in treating cancer, heart disease and other major health conditions in recent decades have extended life spans for millions of people.

However, chronic kidney disease is an outlier, with cases accelerating at a faster pace than all other noninfectious diseases, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System.

The researchers found that the burden of chronic kidney disease, as well as the probability of death related to chronic kidney disease, have increased substantially over the past 15 years in all 50 U.S. states. Such increases also were seen in younger adults ages 20 to 54, a group in which kidney disease had been uncommon.

The findings are published Nov. 30 in JAMA Network Open.

"Unfortunately, chronic kidney disease is known as a 'silent epidemic' because many people don't realize they have it until the disease is at an advanced stage," said Ziyad Al-Aly, MD, the study's senior author and an assistant professor of medicine. "It is particularly concerning that chronic kidney disease is becoming more common in younger people. This is a remarkable move in the wrong direction."

The researchers noted that the abundance of high-sugar, high-salt foods in many American diets and obesity-related health problems such as high blood pressure and type 2 diabetes are likely driving the increase in kidney disease. This is because poor diets and metabolic problems contribute to the buildup of toxins that can interfere with the kidneys' job, which is to remove harmful waste from the body.

The researchers also showed that the increasing rates of chronic kidney disease varied considerably by state. For example, while all states experienced rising rates of chronic kidney disease, significantly higher increases occurred in states with the highest obesity rates among adults -- such as West Virginia, Mississippi, Louisiana, Georgia and Alabama.

"The findings suggest the need to address the health risks such as diabetes that can lead to kidney disease," Al-Aly said. "This means healthier diets and exercise, as well as increased monitoring by health-care workers of patients with obesity or metabolic disorders who are at a greater risk of developing kidney disease."

To compare rates of kidney disease with other diseases, the researchers tapped into a public database of the Global Burden of Disease (GBD) initiative. It provides a detailed epidemiologic assessment of about 350 diseases and injuries by age and sex, as well as more than 80 risk factors, in all U.S. states and countries worldwide. For this study, the analysis focused on U.S. data by age from 2002 to 2016.

The researchers measured and compared the percent change in healthy life-years lost due to kidney disease with the diseases and injuries in the GBD database. They found that chronic kidney disease rates are increasing faster than the rates of all noninfectious diseases, including cardiovascular disease, cancer, cirrhosis and other chronic lung diseases, mental disorders and neurological disorders.

The measure of how many years of healthy life are lost is often referred to as "disability-adjusted life years." During the 15-year period covered by the study, health loss due to kidney disease increased by 18 percent, while the burden of cardiovascular disease and cancer have decreased by 22 percent and 13 percent, respectively.

"The decline is largely reflective of medical advances in cardiovascular disease and cancer treatment," Al-Aly said. "Similarly, the increase in chronic kidney disease reflects a relative stagnation in new treatments. There have been no major advances to slow or reverse kidney disease during the past two decades."

Overall, deaths due to chronic kidney disease increased 58 percent from 52,127 in 2002 to 82,539 in 2016.

While deaths attributable to chronic kidney disease are rare among younger people, the numbers are rising. Among adults ages 20 to 54, the probability of death due to chronic kidney disease increased almost 26.8 percent, from 0.1 percent (or 100 deaths per 100,00 people) in 2002 to 0.125 percent (125 deaths per 100,000 people) in 2016.

"This also is worrisome from an economic perspective because it is the younger adults, in particular, who often contribute most to economic prosperity on local, state and federal levels," Al-Aly said.

Those 55 years and older experienced a 25.6 percent increase in deaths due to chronic kidney disease, from 1.95 percent (1,950 deaths per 100,000 people in 2002 to 2.45 percent (2,450 deaths per 100,000 people) in 2016.

Chronic kidney disease also accounted for a 52 percent increase among all age groups of healthy life-years lost, from 1.2 million in 2002 to 2 million in 2016.

"Public health priorities, policy initiatives, funding allocation and advocacy efforts need to catch up to this reality that the burden of chronic kidney disease is rising, and the speed of change now outpaces other noncommunicable diseases," Al-Aly said. "A concerted effort should be made to put the brakes on this."
-end-


Washington University in St. Louis

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.